Cargando…
FRI262 Can Selective Serotonin Reuptake Inhibitors Unmask Underlying Polyglandular Autoimmune Syndrome Type II?
Disclosure: S. Dehghani: None. S. Kalik: None. J. Zaidan: None. A. Nisar: None. Background: Patients with chronic use of SSRIs are at increased risk of developing hyponatremia secondary to SIADH but a full work up to exclude other etiologies might still be warranted if patient has risk factors. Clin...
Autores principales: | Dehghani, Shabnam, Kalik, Salina, Zaidan, Julie, Nisar, Aqsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554638/ http://dx.doi.org/10.1210/jendso/bvad114.257 |
Ejemplares similares
-
FRI268 Late Onset Polyglandular Autoimmune Syndrome Type 2
por: Nicholson, Matthew S, et al.
Publicado: (2023) -
FRI255 Polyglandular Autoimmune Syndrome Type 2 Presenting With Severe Hyponatremia
por: West, Austin, et al.
Publicado: (2023) -
FRI244 Autoimmune Polyglandular Syndrome Type 2 And Peripartum Cardiomyopathy: A Case Report
por: Jimenez, Aaron-Ross G, et al.
Publicado: (2023) -
FRI271 A Case Of Autoimmune Polyglandular Syndrome Type 2 Presenting With Cardiac Symptoms
por: Lin, Joanne, et al.
Publicado: (2023) -
FRI209 Psychiatric Illness Masking Autoimmune Polyglandular Syndrome In A Middle-aged Woman
por: Esper, Layal, et al.
Publicado: (2023)